View |
|
DR-XY29122
|
Levetiracetam
|
Keppra
|
1 g
|
Film-Coated Tablet
|
Antiepileptic
|
UCB Farchim S.A.
|
Belgium
|
Automatic Renewal
|
31 December 2022
|
04 March 2028
|
View |
|
DR-XY29131
|
Levetiracetam
|
Keppra
|
500 mg
|
Film-Coated Tablet
|
Antiepileptic
|
UCB Pharma SA
|
Belgium
|
Automatic Renewal
|
20 January 2023
|
04 March 2028
|
View |
|
DR-XY29139
|
Prednisone
|
Pred 50
|
50 mg
|
Tablet
|
Corticosteroid
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
22 November 2023
|
10 November 2028
|
View |
DR-XY2914_PI_01.pdf
|
DR-XY2914
|
Naproxen Sodium
|
Flanax Forte
|
550 mg
|
Tablet
|
-
|
Interphil Laboratories, Inc.
|
Philippines
|
-
|
04 August 2020
|
09 January 2026
|
View |
|
DR-XY29140
|
Simvastatin
|
Forcad
|
10 mg
|
Film-Coated Tablet
|
HMG CoA Reductase Inhibitors
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
27 September 2021
|
10 November 2026
|
View |
|
DR-XY29141
|
Phenylephrine Hydrochloride + Brompheniramine Maleate
|
REMEDRIL
|
5 mg/2 mg per 5 mL
|
Syrup
|
Decongestant / Antihistamine
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
18 October 2023
|
11 December 2028
|
View |
|
DR-XY29143
|
Phenylephrine Hydrochloride + Brompheniramine Maleate
|
REMEDRIL
|
1 mg/0.8 mg per mL
|
Syrup (Oral Drops)
|
Decongestant / Antihistamine
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
27 October 2023
|
11 December 2028
|
View |
|
DR-XY29144
|
Sodium Chloride
|
Snif
|
2.3 %
|
Spray Solution
|
-
|
Hizon Laboratories, Inc.
|
Philippines
|
Automatic Renewal (Reconstruction)
|
27 May 2023
|
12 November 2028
|
View |
|
DR-XY29146
|
Co-Amoxiclav
|
Sullivan
|
156.25mg / 5mL
|
Powder For Suspension
|
Antibacterial (Penicillin)
|
Lloyd Laboratories,Inc.
|
Philippines
|
Automatic Renewal
|
21 July 2023
|
11 November 2028
|
View |
|
DR-XY29161
|
Cefaclor (as monohydrate)
|
Ephron
|
500 mg
|
Capsule
|
Antibacterials
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
10 June 2023
|
15 November 2028
|
View |
|
DR-XY29163
|
Omeprazole (as sodium)
|
Ulsek
|
40mg
|
Lyophilized Powder For Injection (I.V.)
|
Proton Pump Inhibitor
|
Standard Chemical and Pharmaceutical Co., Ltd.
|
Taiwan
|
Renewal
|
07 November 2023
|
18 November 2028
|
View |
|
DR-XY29183
|
Water-Soluble Vaitamin: Thiamine Mononitrate 3.1mg (corresponding to Vit B1, 2.5mg), Riboflavin Sodium Phosphate 4.9mg (corresponding to Vit B2, 3.6mg), Nicotinamide 40mg, Pyridoxine Hydrochloride 4.9mg (corresponding to Vit B6 4mg), Cyanocobalamin 5mcg, Sodium Pantothenate 16.5mg (corresponding to Pantothenic Acid, 15mg), Sodium Ascorbate 113mg (corresponding to Vit C, 100mg), Biotin 60mcg, Folic Acid 400mcg
|
Soluvit N
|
See Generic Name
|
Powder for IV Infusion
|
Parenteral Nutrition
|
Sino-Swed Pharmaceutical Corp. Ltd.
|
Sweden
|
Automatic Renewal
|
28 December 2021
|
22 March 2027
|
View |
|
DR-XY29184
|
Hydroxyethyl Starch 130/0.4 + Sodium Chloride
|
Voluven
|
6% / 0.9%
|
Solution For Intravenous Infusion
|
Plasma Expanders/Substitutes
|
Fresenius Kabi Deutschland GmbH
|
Germany
|
Renewal
|
15 November 2023
|
01 December 2028
|
View |
|
DR-XY29187
|
Sodium Chloride
|
Muconase
|
0.0065
|
Solution For Nasal Spray
|
-
|
Hizon Laboratories, Inc.
|
Philippines
|
-
|
22 February 2021
|
28 November 2025
|
View |
|
DR-XY29193
|
Amikacin (as sulfate)
|
Cinmik
|
250 mg/ mL (500 mg/ 2 mL)
|
Solution for Injection (IM/IV)
|
-
|
Karnataka Antibiotics and Pharamceuticla Ltd.
|
India
|
-
|
28 September 2021
|
27 November 2025
|
View |
|
DR-XY29194
|
Amikacin (as Sulfate)
|
Cinmik
|
50 mg/ mL (100 mg/ 2 mL)
|
Solution for Injection (I.M./I.V.)
|
-
|
Karnataka Antibiotics and Pharamceuticla Ltd.
|
India
|
-
|
28 September 2021
|
27 November 2025
|
View |
|
DR-XY29195
|
Phenylpropanolamine Hydrochloride + Brompheniramine Maleate
|
Nazaclir
|
6.25 mg/2 mg per mL
|
Syrup (Oral Drops)
|
Nasal Decongestant/ Antihistamine
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
01 August 2023
|
27 November 2028
|
View |
|
DR-XY29196
|
Phenylephrine Hydrochloride + Chlorphenamine Maleate
|
Bronchofen
|
1.0mg/800mcg
|
Syrup
|
Sympathomimetics used as decongestants
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
19 December 2023
|
27 November 2028
|
View |
|
DR-XY29222
|
Lacipidine
|
Lacipil
|
6 mg
|
Tablet
|
Selective Calcium Channel Blockers with Mainly Vascular Effects (Dihydropyridine derivative)
|
Glaxo Wellcome, S.A.
|
Spain
|
Renewal
|
30 December 2023
|
04 December 2028
|
View |
|
DR-XY29233
|
Remeron-Soltab
|
Mirtazapine
|
15 mg
|
Orodispersible Tablet
|
-
|
Anesta LLC
|
U.S.A.
|
-
|
21 January 2020
|
10 February 2025
|